86 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
written correspondence or notice from the FDA, the European Medicines Agency (the “EMA”), the U.K. Medicines and Healthcare Products Regulatory Agency … (42 U.S.C. Section 1320d et seq.), the exclusion laws (42 U.S.C. §1320a-7), the statutes and regulations of applicable government healthcare programs
8-K
EX-1.2
95iyf39
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
eldlzrruoxt 2u
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
9yun4hn xg5d
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
55z 5p2gpn6e
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
49c7cupx
10 Jul 23
Regulation FD Disclosure
4:06pm
8-K
EX-99.1
v4iknl
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm